# Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)

> **NCT00257647** · — · COMPLETED · sponsor: **Hadassah Medical Organization** · enrollment: 25 (estimated)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

- **OTHER:** SV40 vectors carrying siRNA

## Key facts

- **NCT ID:** NCT00257647
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2009-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00257647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00257647, "Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00257647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*